Tempo Automation Adds Lockheed Martin Investment


Reading time ( words)

Tempo Automation has raised $45 million in Series C funding, led by existing investor, Point72 Ventures. The round includes new outside investors, including Lockheed Martin, as well as existing investors, Lux Capital, Uncork Capital, Cendana and Golden Seeds. The investment will accelerate development of Tempo’s proprietary factory automation software to further increase speed and accuracy for manufacturing high complexity PCB assembly. 

“Tempo is reinventing electronics manufacturing by putting software automation at the center of what they do,” said Sri Chandrasekar, partner at Point72 Ventures and board member at Tempo Automation. “Tempo’s interconnected smart factory is modernizing the manufacturing process, which allows them to deliver a far superior customer experience. We see considerable market opportunity for Tempo, and we are pleased to support their continued growth.”

As technology companies compete to bring groundbreaking innovations to market quickly and gain first-mover advantage, they seek to reduce the time from concept to prototype to product launch. Tempo’s smart factory and proprietary software enable design engineers to ensure precision, speed, and transparency for PCBA.

“We’re fortunate that, by helping our customers apply agile methods to electronics development, we have sparked great interest and demand,” said Jeff McAlvay, CEO of Tempo Automation. “Our customers have told us that they view our software-first approach to manufacturing as transformative for their ability to bring products to market faster. This investment will help us drive software development and accelerate the growth of our team to deliver greater benefits to our customers and advance the future of manufacturing."

To date, Tempo Automation has executed an ambitious growth strategy focused on expanding its footprint with customers across the aerospace, medical technology, industrial systems, consumer electronics, and automotive industries. In 2018, Tempo opened a 42,000-square-foot smart factory in San Francisco’s Design District and released a host of automation software updates that have enabled electrical engineers to design, test, and deploy their products in a fraction of the traditional development cycle time.

As part of this investment, Matthew Granade from Point72 Ventures will join the Tempo board of directors.

About Tempo Automation

Tempo Automation is the world’s fastest electronics manufacturer for prototyping and low-volume production of printed circuit board assemblies. By developing and deploying proprietary factory automation software in its San Francisco-based smart factory, Tempo is changing the way companies in aerospace, medical technology, industrial technology, automotive, and consumer electronics innovate and bring new products to market. Tempo’s industry-leading speed, precision, and start-to-finish transparency enables agile hardware development. Customers are able to plan and execute product development and launch with levels of confidence and certainty not previously possible.

Share

Print


Suggested Items

I-Connect007 Research: How Do You Think 5G Will Impact the Electronics Manufacturing Industry?

07/17/2019 | I-Connect007 Research Team
In a recent I-Connect007 survey on 5G, we asked the following question: How do you think 5G will impact the electronics manufacturing industry? Here are a few of the answers.

Reliability vs. Failure

07/01/2019 | Nolan Johnson, I-Connect007
Summer is officially underway here in the Northern Hemisphere, and just like the temperatures, we’re turning up the heat in this issue and getting technical. Enter “Reliability Man,” the hero who must persevere against all the challenges thrown in his path.

The GraftWorx Fluid Management Patch Story

05/31/2019 | Anthony Flannery, GraftWorx
The GraftWorx vision is to connect patients to clinicians with clinical data that will have a meaningful impact on their care. Its first application is to monitor patients with end-stage renal disease or kidney failure using a wearable device called the SmartPatch that records numerous clinical cardiovascular metrics. This article details how GraftWorx was designed, fabricated, and assembled.



Copyright © 2019 I-Connect007. All rights reserved.